Hayley D. Germack

1.2k total citations
49 papers, 783 citations indexed

About

Hayley D. Germack is a scholar working on General Health Professions, Pulmonary and Respiratory Medicine and Emergency Medical Services. According to data from OpenAlex, Hayley D. Germack has authored 49 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in General Health Professions, 15 papers in Pulmonary and Respiratory Medicine and 12 papers in Emergency Medical Services. Recurrent topics in Hayley D. Germack's work include Global Health Workforce Issues (11 papers), Pulmonary Hypertension Research and Treatments (11 papers) and Nursing Roles and Practices (10 papers). Hayley D. Germack is often cited by papers focused on Global Health Workforce Issues (11 papers), Pulmonary Hypertension Research and Treatments (11 papers) and Nursing Roles and Practices (10 papers). Hayley D. Germack collaborates with scholars based in United States, United Kingdom and Switzerland. Hayley D. Germack's co-authors include Eileen T. Lake, Grant R. Martsolf, Xiaoyi Wang, Md. Noor‐E‐Alam, Md Mahmudul Hasan, Md Saiful Islam, Ryan Kandrack, Linda H. Aiken, Matthew D. McHugh and Linda Hatfield and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Journal of General Internal Medicine.

In The Last Decade

Hayley D. Germack

43 papers receiving 722 citations

Peers

Countries citing papers authored by Hayley D. Germack

Since Specialization

Citations

This map shows the geographic impact of Hayley D. Germack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hayley D. Germack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hayley D. Germack more than expected).

Fields of papers citing papers by Hayley D. Germack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hayley D. Germack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hayley D. Germack. The network helps show where Hayley D. Germack may publish in the future.

Co-authorship network of co-authors of Hayley D. Germack

This figure shows the co-authorship network connecting the top 25 collaborators of Hayley D. Germack. A scholar is included among the top collaborators of Hayley D. Germack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hayley D. Germack. Hayley D. Germack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-World Effectiveness of Budesonide/Glycopyrrolate/Formoterol Fumarate on COPD Exacerbation-Related Healthcare Utilization and Costs: Results from the US Arctos Study 2025 ·American Journal of Respiratory and Critical Care Medicine ·Sanjay Sethi, Hayley D. Germack, Laurence Gozalo, (unknown), (unknown), (unknown), (unknown), Keith Szymanski, Carla Braz Evangelista, Joseph Tkacz	0
2	Location of Care Delivery for Pulmonary Arterial Hypertension in the United States 2025 ·American Journal of Respiratory and Critical Care Medicine ·Peter J. Leary, (unknown), Sumeet Panjabi, John M. Hartney, Amit Goyal, Charlotte Ward, Dwaipayan Mukherjee, Nathan Hatton, Samuel G. Rayner, Hayley D. Germack, John Ryan	1
3	Prompt Initiation of Budesonide/Glycopyrrolate/Formoterol Fumarate (BGF) After an Exacerbation is Associated With Reduced Exacerbation and Cardiopulmonary Risk in Patients With COPD: The MITOS EROS+CP (US) Study 2025 ·American Journal of Respiratory and Critical Care Medicine ·Michael Pollack, (unknown), (unknown), (unknown), (unknown), Hayley D. Germack, Michael G. Crooks, (unknown), Jonathan Marshall, Hana Muellerova	0
4	Prompt initiation of single-inhaler budesonide/glycopyrrolate/formoterol fumarate (BGF) following a COPD exacerbation reduces exacerbations and cardiopulmonary risk in patients with COPD: insights from the MITOS EROS+CP study in the United States 2025 ·Current Medical Research and Opinion ·Michael Pollack, Joseph Tkacz, (unknown), Barnabie Agatep, (unknown), Hayley D. Germack, Michael G. Crooks, Charlie Strange, Jonathan Marshall, Hana Müllerová	1
5	Factors associated with discontinuation of treatment for pulmonary arterial hypertension in the United States 2024 ·Pulmonary Circulation ·Harrison W. Farber, Hayley D. Germack, Nicole S. Croteau, Jason C. Simeone, Fei Tang, Carly J. Paoli, (unknown), Sumeet Panjabi, Teresa De Marco	4
6	Impact of the COVID‐19 pandemic on care disruptions, outcomes, and costs in patients receiving pulmonary arterial hypertension‐specific therapy in the United States of America: An observational study 2023 ·Pulmonary Circulation ·M. Patricia George, Hayley D. Germack, Amit Goyal, Charlotte Ward, Sean Studer, Sumeet Panjabi	2
7	Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH) 2023 ·PharmacoEconomics - Open ·Hilary M. DuBrock, Hayley D. Germack, Marjolaine Gauthier‐Loiselle, (unknown), Ambika Satija, Ameur M. Manceur, Martin Cloutier, Patrick Lefèbvre, Sumeet Panjabi, Robert P. Frantz	3
8	Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis 2023 ·Advances in Therapy ·(unknown), Yuen Tsang, Sumeet Panjabi, (unknown), Hayley D. Germack, Marjolaine Gauthier‐Loiselle, Ameur M. Manceur, Martin Cloutier, Patrick Lefèbvre	2
9	REAL-WORLD ASSOCIATION BETWEEN NONADHERENCE TO PULMONARY ARTERIAL HYPERTENSION MEDICATIONS AND CLINICAL OUTCOMES IN THE US 2023 ·CHEST Journal ·(unknown), Hayley D. Germack, Nicole S. Croteau, Jason C. Simeone, Fei Tang, (unknown), (unknown), (unknown), Teresa De Marco	1
10	Economic burden of illness among patients with pulmonary arterial hypertension (PAH) associated with connective tissue disorders (CTD) 2023 ·Pulmonary Circulation ·Yuen Tsang, Sumeet Panjabi, (unknown), Hayley D. Germack, Marjolaine Gauthier‐Loiselle, Ameur M. Manceur, (unknown), Martin Cloutier, Patrick Lefèbvre	6
11	USE OF MACHINE-LEARNING MODELS TO IDENTIFY CLINICAL FEATURES IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH A FUTURE CLINICAL WORSENING EVENT 2023 ·CHEST Journal ·Hilary M. DuBrock, Tobore Onojighofia Tobore, Hayley D. Germack, (unknown), (unknown), (unknown), (unknown), Eli Silvert, (unknown)	1
12	Relationship between rural hospital closures and the supply of nurse practitioners and certified registered nurse anesthetists 2021 ·Nursing Outlook ·Hayley D. Germack, Ryan Kandrack, Grant R. Martsolf	8
13	Methodology for a six-state survey of primary care nurse practitioners 2021 ·Nursing Outlook ·Jordan M. Harrison, Hayley D. Germack, Lusine Poghosyan, Thomas D’Aunno, Grant R. Martsolf	23
14	Community socioeconomic disadvantage drives type of 30-day medical-surgical revisits among patients with serious mental illness 2021 ·BMC Health Services Research ·Hayley D. Germack, (unknown), (unknown), Heather K. Vincent, (unknown), Grant R. Martsolf	1
15	Psychiatric Medication Changes Associated With Increased Rate of Medical Readmissions in Patients With Serious Mental Illness 2020 ·The Journal of Nervous and Mental Disease ·Hayley D. Germack, (unknown), (unknown), Grant R. Martsolf	4
16	Caring for Patients With Opioid Use Disorder in the Midst of a Pandemic 2020 ·Journal of Addictions Nursing ·(unknown), (unknown), Hayley D. Germack	1
17	The Interdisciplinary Research Group on Nursing Issues: Advancing Health Services Research, Policy, Regulation, and Practice 2019 ·Journal of Nursing Regulation ·Allison Squires, Hayley D. Germack, Ulrike Muench, Deonni P. Stolldorf, Amy Witkoski Stimpfel, Olga Yakusheva, Heather Brom, Jordan M. Harrison, (unknown), (unknown), Grant R. Martsolf	2
18	Medical-surgical readmissions in patients with co-occurring serious mental illness: A systematic review and meta-analysis 2018 ·General Hospital Psychiatry ·Hayley D. Germack, (unknown), Rachel Solomon, Nancy P. Hanrahan	16
19	Nurse Engagement in Shared Governance and Patient and Nurse Outcomes 2016 ·JONA The Journal of Nursing Administration ·Ann Kutney‐Lee, Hayley D. Germack, Linda Hatfield, Sharon Kelly, Patricia Maguire, Andrew Dierkes, Mary Del Guidice, Linda H. Aiken	100
20	Patient satisfaction and non-UK educated nurses: a cross-sectional observational study of English National Health Service Hospitals 2015 ·BMJ Open ·Hayley D. Germack, Peter Griffiths, Douglas M. Sloane, Anne Marie Rafferty, Jane Ball, Linda H. Aiken	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact